{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:07:01Z","timestamp":1768450021956,"version":"3.49.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003345","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T16:03:01Z","timestamp":1417708981000},"page":"e3345","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Quality of Medicines Commonly Used in the Treatment of Soil Transmitted Helminths and Giardia in Ethiopia: A Nationwide Survey"],"prefix":"10.1371","volume":"8","author":[{"given":"Sultan","family":"Suleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemechu","family":"Zeleke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habtewold","family":"Deti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeleke","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Duchateau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Levecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"D'Hondt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Wynendaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"De Spiegeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1756-3305-5-135","article-title":"Intestinal parasitic infections in schoolchildren in different settings of C\u00f4te d&apos;Ivoire: effect of diagnostic approach and implications for control","volume":"5","author":"JT Coulibaly","year":"2012","journal-title":"Parasit Vectors"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(06)68653-4","article-title":"Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm","volume":"367","author":"J Bethony","year":"2006","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"PJ Hotez","year":"2007","journal-title":"N Engl J Med"},{"key":"ref4","first-page":"169","article-title":"Helminth parasites, a major factor in malnutrition","volume":"15","author":"LS Stephenson","year":"1994","journal-title":"World Health Forum"},{"key":"ref5","unstructured":"Vecchiato NL (1997) Digestive worms: ethnomedical approaches to intestinal parasitism in southern Ethiopia. In Inhorn MC, Brown PJ, editors. The Anthropology of Infectious Disease: international health perspectives. Amsterdam: Gorden and Breach publishers. pp. 241\u2013266."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/157016206775197682","article-title":"Intestinal parasite infestation in HIV infected patients","volume":"4","author":"V Wiwanitkit","year":"2006","journal-title":"Curr HIV Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-308X(10)73008-6","article-title":"The drugs we have and the drugs we need against major helminth infections","volume":"73","author":"J Keiser","year":"2010","journal-title":"Adv Parasitol"},{"key":"ref8","unstructured":"WHO (2006) Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s004360050640","article-title":"Anthelmintic efficacy of tinidazole against the progression of <italic>Toxocara canis<\/italic> larvae to the brain in mice","volume":"85","author":"MC Minvielle","year":"1999","journal-title":"Parasitol Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"J Keiser","year":"2008","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0001-706X(03)00046-9","article-title":"Experience with school-based interventions against soil-transmitted helminths and extension of coverage to non-enrolled children","volume":"86","author":"A Olsen","year":"2003","journal-title":"Acta Trop"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jps.22391","article-title":"Ensuring global access to quality medicines: Role of the US pharmacopeia","volume":"100","author":"ML Heyman","year":"2011","journal-title":"J Pharm Sci"},{"key":"ref13","unstructured":"WHO (2012) Medicines: spurious\/falsely-labelled\/falsified\/counterfeit (SFFC) medicines. Geneva: World Health Organization."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1365-3156.2008.02106.x","article-title":"Substandard medicines in resource-poor settings: a problem that can no longer be ignored","volume":"13","author":"JM Caudron","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref15","first-page":"1423","article-title":"Update on counterfeit drugs: a growing risk for public health","volume":"192","author":"Y Juillet","year":"2008","journal-title":"Bull Acad Natl Med"},{"key":"ref16","first-page":"205","article-title":"Problems associated with substandard and counterfeit drugs in developing countries: A review article on global implications of counterfeit drugs in the era of anti-retroviral (ARVS) drugs in a free market economy","volume":"5","author":"SE Nsimba","year":"2008","journal-title":"East Afr J Public Health"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00002018-200326140-00001","article-title":"Health risks of counterfeit pharmaceuticals","volume":"26","author":"M Ten Ham","year":"2003","journal-title":"Drug Safety"},{"key":"ref18","unstructured":"WHO (2011) Survey of the quality of selected anti-malarial medicines circulating in six countries of sub-Saharan Africa. Geneva: World Health Organization."},{"key":"ref19","unstructured":"WHO (1999) Specifications for prepackaging anti-malarial medicines. Geneva: World Health Organization."},{"key":"ref20","unstructured":"Nasr N (2004) Risk Based CMC Review Paradigm. Presentation at FDA Advisory Committee for Pharmaceutical Science Meeting, July 20\u201321. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/slides\/2004-4052S1_10_Nasr.ppt\" xlink:type=\"simple\">http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/slides\/2004-4052S1_10_Nasr.ppt<\/ext-link>. Accessed 21 January 2013."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Chakraborty AK, Borah GK (1989) An application of the concept of desirability functions in evaluating erection quality. Qual Eng: 443\u2013452.","DOI":"10.1080\/08982118908962679"},{"key":"ref22","unstructured":"Derringer GC (1994) A balancing act: optimizing a product&apos;s properties. Quality Progress, 51\u201358. American Society for Quality."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1000052","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: A proposal","volume":"6","author":"PN Newton","year":"2009","journal-title":"PLoS Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.2042-7158.1998.tb03303.x","article-title":"Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide","volume":"50","author":"H Jung","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18433\/J3K308","article-title":"Nanosponges: A novel class of drug delivery system \u2013 review","volume":"15","author":"S Subramanian","year":"2012","journal-title":"J Pharm Pharmaceut Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0928-0987(00)00181-0","article-title":"In vitro\u2013in vivo correlations for lipophilic, poorly water-soluble drugs","volume":"11","author":"JB Dressman","year":"2000","journal-title":"Eur J of Pharm Sci"},{"key":"ref27","article-title":"Practitioner&apos;s guide to statistics and lean six sigma for process improvements","author":"MJ Harry","year":"2010","journal-title":"Wiley"},{"key":"ref28","unstructured":"International Conference on Harmonization, editor (2006) Guidance for Industry Q9-Quality Risk Management."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1108\/02656710010353885","article-title":"MAFMA: Multi-attribute failure mode analysis","volume":"17","author":"M Braglia","year":"2000","journal-title":"Int J Qual Reliab Manage"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.microrel.2009.07.057","article-title":"Evaluate the orderings of risk for failure problems using a more general RPN methodology","volume":"49","author":"KH Chang","year":"2009","journal-title":"Microelectron Reliab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(00)05065-0","article-title":"Pharmacopoeial quality of drugs supplied by Nigerian pharmacies","volume":"357","author":"RB Taylor","year":"2001","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/vr.142.15.396","article-title":"Pharmaceutical quality of anthelmintics sold in Kenya","volume":"142","author":"A Monteiro","year":"1998","journal-title":"Vet Rec"},{"key":"ref33","first-page":"93","article-title":"Quality Assessment of the Commonly Prescribed Antimicrobial Drug, Ciprofloxacin Tablets, Marketed in Tigray, Ethiopia","volume":"2","author":"G Kahsay","year":"2010","journal-title":"Memona Ethiop J Sci"},{"key":"ref34","first-page":"147","article-title":"Comparative evaluation of invitro characteristics of tablets of the commonly prescribed antiepileptic drugs: carbamazepine and phenobarbitone","volume":"17","author":"S Suleman","year":"2007","journal-title":"Ethiop J Health Sci"},{"key":"ref35","first-page":"119","article-title":"Optimization of correlated multiple quality characteristics using desirability function","volume":"17","author":"FC Wu","year":"2005","journal-title":"Qual Engng"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/qre.939","article-title":"Multiresponse optimization of products with functional quality characteristics","volume":"24","author":"FS Fogliatto","year":"2008","journal-title":"Qual Reliab Engng Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1134\/S1070363211130111","article-title":"Harrington&apos;s Desirability Function for Natural Water Quality Assessment","volume":"81","author":"ES Bikbulatov","year":"2011","journal-title":"Russ J Gen Chem"},{"key":"ref38","unstructured":"International Conference on Harmonization, editor (2006) Guidance for Industry Q8-Pharmaceutical Development."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e7381","DOI":"10.1136\/bmj.e7381","article-title":"How to achieve international action on falsified and substandard medicines","volume":"345","author":"A Attaran","year":"2012","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00216-010-3912-4","article-title":"Quality analytics of internet pharmaceuticals","volume":"398","author":"B Baert","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"ref41","unstructured":"WHO (2009) Survey of the quality of selected anti-malarial medicines circulating in Madagascar, Senegal, and Uganda. Geneva: World Health Organization."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2875-8-22","article-title":"Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria","volume":"8","author":"O Onwujekwe","year":"2009","journal-title":"Malar J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jac\/dkm109","article-title":"Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence","volume":"60","author":"T Kelesidis","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref44","first-page":"639","article-title":"Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia","volume":"15","author":"MH Khan","year":"2010","journal-title":"Trop Med Int Health"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S1473-3099(12)70241-4","article-title":"Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems","volume":"12","author":"AO Talisuna","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0731-7085(98)00269-6","article-title":"Uniformity of dosage units: comparative study of methods and specifications between Eur. Pharm. 3rd and USP 23","volume":"18","author":"JM Martins","year":"1998","journal-title":"J Pharm Sci Biomed Anal"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e25003","DOI":"10.1371\/journal.pone.0025003","article-title":"Efficacy of single-dose and triple-dose albendazole and mebendazole against soil-transmitted helminths and taenia sppecies: a randomized controlled trial","volume":"6","author":"P Steinmann","year":"2011","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1208\/s12248-008-9034-7","article-title":"Clinical relevance of disssolution testing in quality by design","volume":"10","author":"PA Dickinson","year":"2008","journal-title":"AAPS J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1051\/parasite\/200108s2195","article-title":"Efficacy of flubendazole and albendazole against <italic>Trichinella spiralis<\/italic> in mice","volume":"8","author":"MS Chung","year":"2001","journal-title":"Parasite"},{"key":"ref50","first-page":"S257","article-title":"Efficacy of albendazole against early and late stage of Trichinella spiralis infection in mice","volume":"86","author":"P Siriyasatien","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/jps.22072","article-title":"Enantiotropically related albendazole polymorphs","volume":"99","author":"MB Pranzo","year":"2010","journal-title":"J Pharm Sci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2010.10.002","article-title":"Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity","volume":"403","author":"JJ Garc\u00eda-Rodrigueza","year":"2011","journal-title":"Int J Pharmaceutics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2003.11.030","article-title":"The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs","volume":"272","author":"K Daniel-Mwambete","year":"2004","journal-title":"Int J Pharmaceutics"},{"key":"ref54","first-page":"220","article-title":"Polymorphism evaluation in generic tablets containing mebendazole by dissolution tests","volume":"23","author":"SB Honorato","year":"2012","journal-title":"J Braz Chem Sos"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jps.21899","article-title":"Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole","volume":"99","author":"M Brits","year":"2010","journal-title":"J Pharm Sci"},{"key":"ref56","first-page":"71","article-title":"Crystal polymorphism of pharmaceuticals","volume":"40","author":"L Borka","year":"1990","journal-title":"Acta Pharm Jugosl"},{"key":"ref57","unstructured":"WHO (2002) Strategy development and monitoring for parasitic diseases and vector control (PVC), control, prevention and eradication (CPE) programme on communicable diseases (CDS). Geneva: World Health Organization."},{"key":"ref58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0001-706X(03)00031-7","article-title":"Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics","volume":"86","author":"AD Dayan","year":"2003","journal-title":"Acta Trop"},{"key":"ref59","unstructured":"FMHACA (2010) Standard Treatment Guidelines for General Hospitals. Drug Adminstration and Control Authority, Addis Ababa, Ethiopia."},{"key":"ref60","first-page":"14","article-title":"Is anthelmintic resistance a concern for the control of human soil-transmitted helminths?","volume":"1","author":"J Vercruysse","year":"2011","journal-title":"Int J Parasitol: Drugs and Drug Resistance"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0360-8352(99)00049-2","article-title":"Web-based failure mode and effect analysis","volume":"37","author":"GQ Hung","year":"1999","journal-title":"Comput Ind Eng"},{"key":"ref62","unstructured":"United States MIL-STD 1629-A (1998) Procedure for performing a failure mode, effects and criticality analysis. Department of Defense, Washington, DC."},{"key":"ref63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.chroma.2005.04.081","article-title":"Simultaneous optimization of the resolution and analysis time in micellar liquid chromatography of phenyl thiohydantoin amino acids using Derringer&apos;s desirability function","volume":"1078","author":"F Safa","year":"2005","journal-title":"J Chromatogr A"},{"key":"ref64","first-page":"29","article-title":"Global optimization using Derringer&apos;s desirability function: Enantioselective determination of ketoprofen in formulations and in biological matrices","volume":"19","author":"T Sivakumar","year":"2007","journal-title":"Acta Chromatogr"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/psc.1323","article-title":"Desirability function combining metabolic stability and functionality of peptides","volume":"17","author":"S Van Dorpe","year":"2011","journal-title":"J Pept Sci"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"D&apos;Hondt M, Verbeke F, Stalmans S, Gevaert B, Wynendaele E, <etal>et al<\/etal>.. (2013) Derringer desirability and kinetic plot LC-column comparison approach for MS-compatible lipopeptide analysis. J Pharm Anal <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.jpha.2013.09.001\" xlink:type=\"simple\">http:\/\/dx.doi.org\/10.1016\/j.jpha.2013.09.001<\/ext-link>.","DOI":"10.1016\/j.jpha.2013.09.001"},{"key":"ref67","unstructured":"Segall MD (2009) Multi-Parameter Optimization: Identifying high quality compounds with a balance of properties. Optibrium Ltd, Cambridge, UK."}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T17:45:48Z","timestamp":1540316748000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003345"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Keiser","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003345","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,4]]}}}